Stop using nowMedical device recall · FDA · Published June 8, 2023
Argon Medical Elite Vena Cava Filter Recall: Pulmonary Embolism Risk
Argon Medical recalls Elite Retrievable Vena Cava Filters due to potential failure causing pulmonary embolism. Affected units have specific model and lot numbers.
“Argon Medical Elite Vena Cava Filter Recall: Pulmonary Embolism Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/57877-argon-medical-elite-vena-cava-filter-recall-pulmonary-embolism-risk. Based on FDA recall #Z-2239-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2239-2023%22&limit=1).
The FDA announced on June 8, 2023, that Argon Medical Devices, Inc. is recalling its Option Elite Retrievable Vena Cava Filter due to potential performance failure leading to pulmonary embolism. The agency issued recall number Z-2239-2023 for the Class II device distributed in Texas.
How to tell if you have it
Brand: Argon Medical
Product: Option Elite Retrievable Vena Cava Filter, Suitable of Jugular or Femoral Delivery
REF: 352506070E
Lot: 11481383
UDI: (00)886333217151
The hazard
According to the FDA, the vena Cava Filter may not perform as intended, which may result in pulmonary embolism. The record does not report specific incidents or injuries associated with this recall.
Context
GovInfoNow's records show Argon Medical Devices, Inc. has 15 other recalls on record since October 16, 2018. Other recent recalls of similar products include Medline Oxygen Masks Recall (November 21, 2025), Boston Scientific FARADRIVE Steerable Sheath Recall (June 11, 2026), and Medline ViewFlex Xtra ICE Catheters Recall (December 22, 2025).
How to tell if you have this one
Check for the model number REF 3525060: 352506070E on the device or packaging. Lot number 11481383 and UDI (00)886333217151 are also identifiers.
Brand
Argon Medical
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discontinue use of the Elite Retrievable Vena Cava Filter if it is the recalled model.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide distribution in the state of TX.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 55 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2239-2023 (June 8, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2239-2023 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.